Iambic Therapeutics

Iambic is a clinical-stage life sciences & technology company developing novel medicines using its AI-driven platform. Based in San Diego and founded in 2020, Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters.

The Iambic platform has demonstrated delivery of new drug candidates to human clinical trials with industry-leading speed and across multiple target classes and mechanisms of action.

Iambic is advancing a disease-agnostic pipeline of potential best-in-class and first-in-class medicines to address urgent unmet patient need. Learn more at iambic.ai